Men's Knowledge About Contraception (contracep-men)

February 13, 2026 updated by: Université de Reims Champagne-Ardenne

Contraception is defined as all the means to prevent pregnancy. It is therefore a public health issue. To make informed and responsible decisions about contraception, it is essential to inform and educate the entire population on this subject. Knowledge of contraception is an element that can reduce the number of unwanted pregnancies and consequently the number of voluntary abortions.

Despite the law of 4 July 2011 which provided for the duty to access information and education on sexuality during schooling and the sexual health strategy put in place for the period 2017-2030, the rate of voluntary terminations of pregnancy in 2022 was the highest ever recorded at 234,300, representing a considerable cost of around 165 million euros for social security. There is obviously a lack of sex education, but that's only part of the problem.

Indeed, the right choice of contraceptive and the proper understanding of its use are necessary to reduce the gap between the theoretical and practical effectiveness of contraception and thus decrease the number of unwanted pregnancies. According to a 2017 study, 54% of women said they were insufficiently informed about the contraceptive they use. Given the lack of studies on men's knowledge about contraception, it would be necessary to evaluate their achievements in order to adapt sexual education to all and thus reduce the risk of unwanted pregnancies in couples.

Midwives are particularly concerned because they have the power to prescribe contraception and play a full role in the sexual education of couples.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The main objective is to describe men's knowledge of contraception.

Study Type

Observational

Enrollment (Actual)

459

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Reims, France, 51100
        • Ufr Medecine Urca

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

adult heterosexual men living in France (including overseas departments and territories), from all socio-professional categories, who agreed to take part in the study.

Description

Inclusion Criteria:

  • male
  • of legal age
  • heterosexual
  • living in mainland France and the French overseas departments and territories
  • from all socio-professional categories
  • who agreed to take part in the study

Exclusion Criteria:

  • females
  • minors
  • non-heterosexual
  • protected by law (guardianship, curatorship, safeguard of justice)
  • who refuse to take part in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire on men's knowledge of contraception
Time Frame: Day 0

Men's knowledge of female and male contraception they will be assessed using a questionnaire developed by a team composed of midwives and methodologists

The questions will cover:

Female contraception: methods, mechanisms of action and use. Male contraception: methods, mechanisms of action and use.
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Université de Reims Champagne-Ardenne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2024

Primary Completion (Actual)

January 25, 2025

Study Completion (Actual)

February 1, 2025

Study Registration Dates

First Submitted

February 6, 2026

First Submitted That Met QC Criteria

February 13, 2026

First Posted (Actual)

February 17, 2026

Study Record Updates

Last Update Posted (Actual)

February 17, 2026

Last Update Submitted That Met QC Criteria

February 13, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024_RIPH_13-contracep-men

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Contraception

Clinical Trials on data collection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe